PPL-001

N/A

Report date: 2024/11/07 09:28:17

Base Information

Drug NamePPL-001
Drug Alias NameHSPC-FXNPPL-001
ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionFrataxin, mitochondrial stimulants
TargetsFrataxin, mitochondrial
Therapy Area/IndicationsFriedreich Ataxia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPapillon Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPapillon Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsFriedreich Ataxia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A